T Staalsoe1, H A Giha, D Dodoo, T G Theander, L Hviid. 1. Centre for Medical Parasitology at RHIMA Centre, Copenhagen University Hospital (Rigshospitalet) and Institute for Medical Microbiology and Immunology, University of Copenhagen, Denmark. tscmp@rh.dk
Abstract
BACKGROUND: Naturally induced antibodies binding to surface antigens of Plasmodium falciparum-infected erythrocytes can be detected by direct agglutination of infected erythrocytes or by indirect immunofluorescence on intact, unfixed, infected erythrocytes. Agglutinating antibodies have previously been shown to recognise Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). This protein is inserted by the parasite into the host cell membrane and mediates the adhesion to the venular endothelium of the host organism in vivo. METHODS: Erythrocytes infected at high parasitaemias with ethidium-bromide-labelled mature forms of P. falciparum parasites were sequentially exposed to immune plasma, goat anti-human immunoglobulin (Ig) G, and fluorescein-isothiocyanate-conjugated rabbit anti-goat Ig. Plasma antibodies recognising antigens exposed on the surface of parasitised erythrocytes were subsequently detected by two-colour flow cytometry. RESULTS: Binding of human antibodies to the surface of erythrocytes infected with adhesive strains of Plasmodium falciparum can be measured by the two-colour flow cytometry (FCM) assay described. In addition, we demonstrate that the adhesive capacity of a parasite isolate correlates with the capacity of human immune plasmas to label the isolate as detected by FCM. We also show that the antigens recognised by the labelling antibodies are strain specific and that their molecular weights are in the range previously described for PfEMP1 antigens. CONCLUSIONS: Our FCM assay predominantly detects antibodies that recognise PfEMP1 and thus constitutes a convenient assay for the analysis of acquisition, maintenance, and diversity of anti-PfEMP1-specific antibodies and for the examination of class and subclass characteristics.
BACKGROUND: Naturally induced antibodies binding to surface antigens of Plasmodium falciparum-infected erythrocytes can be detected by direct agglutination of infected erythrocytes or by indirect immunofluorescence on intact, unfixed, infected erythrocytes. Agglutinating antibodies have previously been shown to recognise Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). This protein is inserted by the parasite into the host cell membrane and mediates the adhesion to the venular endothelium of the host organism in vivo. METHODS: Erythrocytes infected at high parasitaemias with ethidium-bromide-labelled mature forms of P. falciparum parasites were sequentially exposed to immune plasma, goat anti-human immunoglobulin (Ig) G, and fluorescein-isothiocyanate-conjugated rabbit anti-goat Ig. Plasma antibodies recognising antigens exposed on the surface of parasitised erythrocytes were subsequently detected by two-colour flow cytometry. RESULTS: Binding of human antibodies to the surface of erythrocytes infected with adhesive strains of Plasmodium falciparum can be measured by the two-colour flow cytometry (FCM) assay described. In addition, we demonstrate that the adhesive capacity of a parasite isolate correlates with the capacity of human immune plasmas to label the isolate as detected by FCM. We also show that the antigens recognised by the labelling antibodies are strain specific and that their molecular weights are in the range previously described for PfEMP1 antigens. CONCLUSIONS: Our FCM assay predominantly detects antibodies that recognise PfEMP1 and thus constitutes a convenient assay for the analysis of acquisition, maintenance, and diversity of anti-PfEMP1-specific antibodies and for the examination of class and subclass characteristics.
Authors: Michael F Ofori; Trine Staalsoe; Victoria Bam; Maja Lundquist; Kim P David; Edmund N L Browne; Bartholomew D Akanmori; Lars Hviid Journal: Infect Immun Date: 2003-03 Impact factor: 3.441
Authors: Amy K Bei; Ababacar Diouf; Kazutoyo Miura; Daniel B Larremore; Ulf Ribacke; Gregory Tullo; Eli L Moss; Daniel E Neafsey; Rachel F Daniels; Amir E Zeituni; Iguosadolo Nosamiefan; Sarah K Volkman; Ambroise D Ahouidi; Daouda Ndiaye; Tandakha Dieye; Souleymane Mboup; Caroline O Buckee; Carole A Long; Dyann F Wirth Journal: Infect Immun Date: 2014-11-03 Impact factor: 3.441
Authors: Lea Barfod; Tina Dobrilovic; Pamela Magistrado; Pongsak Khunrae; Firmine Viwami; Jonas Bruun; Madeleine Dahlbäck; Nadia L Bernasconi; Michal Fried; Davis John; Patrick E Duffy; Ali Salanti; Antonio Lanzavecchia; Chwee Teck Lim; Nicaise Tuikue Ndam; Matthew K Higgins; Lars Hviid Journal: J Immunol Date: 2010-11-15 Impact factor: 5.422
Authors: Rikke N Haase; Rosette Megnekou; Maja Lundquist; Michael F Ofori; Lars Hviid; Trine Staalsoe Journal: Infect Immun Date: 2006-05 Impact factor: 3.441
Authors: John P A Lusingu; Anja T R Jensen; Lasse S Vestergaard; Daniel T Minja; Michael B Dalgaard; Samwel Gesase; Bruno P Mmbando; Andrew Y Kitua; Martha M Lemnge; David Cavanagh; Lars Hviid; Thor G Theander Journal: Infect Immun Date: 2006-05 Impact factor: 3.441
Authors: Hanne L Ziegler; Harald S Hansen; Dan Staerk; Søren Brøgger Christensen; Henry Hägerstrand; Jerzy W Jaroszewski Journal: Antimicrob Agents Chemother Date: 2004-10 Impact factor: 5.191
Authors: Trine Staalsoe; Caroline E Shulman; Edgar K Dorman; Ken Kawuondo; Kevin Marsh; Lars Hviid Journal: Infect Immun Date: 2004-09 Impact factor: 3.441